NCT05900934

The Effects Of Myofascial Release In Combined With Task-Oriented Circuit Training On Balance And Gait In People With Parkinson's Disease

Status unknown NA Last updated 29 February 2024

What this trial tests

NA trial testing Myofascial Releasing Group in Parkinson Disease in 36 participants. Status unknown.

Timeline

15 June 2023

Primary endpoint
15 June 2024

15 September 2024

Quick facts

Lead sponsor	Hacettepe University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	36
Start date	15 June 2023
Primary completion	15 June 2024
Estimated completion	15 September 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• Myofascial Releasing Group
• Sham Myofascial Releasing Group

Conditions studied

• Parkinson Disease — all drugs for Parkinson Disease →
• Myofascial Release — all drugs for Myofascial Release →
• Exercise Therapy — all drugs for Exercise Therapy →
• Movement Disorders — all drugs for Movement Disorders →

Sponsor

Hacettepe University

Who can join

Adults 18 to 100, any sex, with Parkinson Disease or Myofascial Release. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators plan to have Parkinson's patients perform exercises according to the task-oriented training method. Since recent studies have suggested that task-oriented training should be organized as a series of workstations that allow for more intensive practice, each of them has a program content implemented in the form of a station. The program will be implemented in 11 different stations with 3 minutes and a 1-minute break at each station, 3 days a week for 8 weeks under the supervision and guidance of a physiotherapist. The task-oriented training program will be carried out by applying the above-mentioned exercises in the form of stations sequentially within a certain period of time. For all exercises, the intensity perceived by the individuals will be ensured to be 12-15 points of perceived exertion according to the Borg Perceived Exertion Scale. In this way, the exercise program can be easily individualized according to the participant's pain, complaints, and functional status. In the study, after the task-oriented approach, foam roller application and myofascial release will be applied at the end of each session.

Foam roller application; C7-T1 and posterior neck region, thoracic spine, lumbar spine, and right and left sides of the thoracolumbar spine will be applied with a foam roller, which is a myofascial release device, in each session. Each application area will be applied in 3 sets of 60 seconds of application and 30 seconds of rest. The intensity of the pressure for the intensity of the application will be subjectively controlled with a target numeric rating scale rating of 7/10 (0 represents no discomfort and 10 represents maximum discomfort). In the sham group, similar to the literature, the intensity of the application will be applied in accordance with the 0/10 numeric rating scale, at the same application sites, for the same duration and the same rest intervals.

Within the scope of this study, participants gait, balance, rotation time, range of motion, level of achievement of the treatment goal, quality of life and trunk impairment will be evaluated at the beginning of the study and at the end of 8 weeks.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. The effects of myofascial release in combined with task-oriented circuit training on balance in people with Parkinson's disease: a randomized pilot trial.
   Kaşlı K, Doğan M, Özal C, Doğan Y, et al · · 2024 · cited 1× · PMID 38818769 · DOI 10.1080/01616412.2024.2360860
2. The Effects of Foam Rolling after Task-Oriented Circuit Training on Gait, Balance, and Range of Motion in Parkinson's Disease: A Randomised Controlled Trial.
   Kaşlı K, Doğan M, Özal C, Doğan Y, et al · · 2026 · PMID 41452784 · DOI 10.1159/000550230